Healthspan Economy

ClinicalTrials.gov · NCT06249620 · Completed

Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age.

Registry record

NCT06249620 on ClinicalTrials.gov. The registry's last update to this record was 8 February 2024.

Date checked: . This is the day the Atlas read the registry record; the registry may have changed since.

Verification record

5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked

  • Title as registered Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age. Checked Source clinicaltrials.gov Brief title as registered. Checked
  • Sponsor Industrial Farmacéutica Cantabria, S.A. Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
  • Intervention Inmunoferon; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
  • Primary outcome as registered Change in Biological Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
  • Status Completed Checked Source clinicaltrials.gov Overall status as registered; registry last update 2024-02-08. Checked

Check history: NCT06249620 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.

Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.

As registered

  • Sponsor: Industrial Farmacéutica Cantabria, S.A.
  • Phase: Not applicable
  • Status: Completed
  • Intervention: Inmunoferon; Placebo
  • Primary outcome: Change in Biological Age
  • Countries: Spain
  • Start: 19 April 2022
  • Completion (actual): 1 October 2022

Results

No results were posted on the registry on the date checked. The Atlas does not summarize findings.

A trial being registered is not evidence that the intervention works.